Currently out of the existing stock ratings of Louise Chen, 569 are a BUY (92.67%), 44 are a HOLD (7.17%), 1 are a SELL (0.16%).

Louise Chen

Work Performance Price Targets & Ratings Chart

Analyst Louise Chen, currently employed at SCOTIABANK, carries an average stock price target met ratio of 42.82% that have a potential upside of 27.01% achieved within 280 days.

Louise Chen’s has documented 1,111 price targets and ratings displayed on 86 stocks. The coverage is on Healthcare, Industrials, Energy, Utilities sectors.

Most recent stock forecast was given on MRK, Merck mpany at 30-Jun-2026.

Wall Street Analyst Louise Chen

Analyst best performing recommendations are on THTX (THERATECHNOLOGIES).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 2/27/2019. The price target of $26 was fulfilled within 1 day with a profit of $4.15 (18.99%) receiving and performance score of 189.93.

Average potential price target upside

of $114.57 (82.49%) on AMRN (AMARIN PLC).
of $62.23 (42.91%) on JNJ (JOHNSON & JOHNSON).
of $58.67 (69.46%) on TXMD (THERAPEUTICSMD).

ACRS Aclaris Therapeutics AGN Allergan plc AMRN Amarin PLC ANIP ANI Pharmaceuticals ARDX Ardelyx ENDP Endo International PLC ETTX Entasis Therapeutics Holdings HGEN Humanigen HZNP Horizon Pharma PLC IMAB I-Mab JNJ Johnson & Johnson LLY Eli Lilly and Company MNK Mallinckrodt plc MYL Viatris PFE Pfizer PRGO Perrigo Company PLC SOLY Soliton TEVA Teva Pharma Industries Ltd ADR TXMD TherapeuticsMD ZTS Zoetis EFTR Effector Therapeutics EOLS Evolus MRK Merck mpany CRXT Clarus Therapeutics Holdings OSMT Osmotica Pharmaceuticals plc RVNC Revance The CFRX ContraFect Corp TBPH Theravance Biopharma VTRS Viatris ZTO ZTO Express (Cayman) HRTX Heron Therapeuti SPRO Spero Therapeutics MDCO The Medicines Company AERI Aerie Pharmaceuticals PAHC Phibro Animal Health PCVX Vaxcyte JAZZ Jazz Pharmaceuticals PLC ARAV Aravive ARDS Aridis Pharmaceuticals CDTX Cidara Therapeutics CUTR Cutera HCM HUTCHMED DRC MESO Mesoblast Ltd OPK Opko Health PRTK Paratek Pharmaceuticals RVLP RVL Pharmaceuticals PLC SCYX Scynexis THTX Theratechnologies AKRX Akorn ARQT Arcutis Biotherapeutics ROIV Roivant Sciences Ltd VYNE Vyne Therapeutics AMAM Ambrx Biopharma American Depositary Shares IMVT Immunovant ZLAB Zai Lab Ltd NVO Novo Nordisk A/S ABBV AbbVie INVA Innoviva LYRA Lyra Therapeutics ANL Adlai Nortye Ltd. American Depositary Shares ATOS Atossa Genetics NBRV Nabriva Therapeutics AG NEOS Neos Therapeutics SRPT Sarepta Therapeutics TTPH Tetraphase Pharmaceuticals JAGX BMY Bristol-Myers Squibb Company REGN Regeneron Pharmaceuticals ACT Enact Holdings AER AerCap Holdings NV AMRX Amneal Pharmaceuticals, Common Stock BPMC Blueprint Medicines Corp CERC Cerecor COGT Cogent Biosciences CR Crane Company DERM Journey Medical Corp DYN Dyne Therapeutics ET Energy Transfer LP EWTX Edgewise Therapeutics HG Hamilton Insurance Group, Ltd. MNLO Menlo Therapeutics OS OneStream, Common Stock RNA Avidity Biosciences SO Southern Company SPRY ARS Pharmaceuticals GILD Gilead Sciences

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Raghuram Selvaraju (HC WAINWRIGHT)